INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 160 filers reported holding INTELLIA THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is 1.73 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $77,785 | -96.9% | 2,460 | -96.1% | 0.00% | -94.7% |
| Q2 2023 | $2,546,711 | +3441401.4% | 62,450 | +3054.0% | 0.02% | +1800.0% |
| Q1 2023 | $74 | +8.8% | 1,980 | +1.0% | 0.00% | 0.0% |
| Q4 2022 | $68 | -99.9% | 1,960 | -5.4% | 0.00% | 0.0% |
| Q3 2022 | $109,000 | +38.0% | 2,072 | +36.3% | 0.00% | 0.0% |
| Q2 2022 | $79,000 | -41.9% | 1,520 | -18.7% | 0.00% | 0.0% |
| Q1 2022 | $136,000 | -53.4% | 1,870 | -39.5% | 0.00% | -50.0% |
| Q4 2021 | $292,000 | -91.8% | 3,090 | -88.3% | 0.00% | -90.9% |
| Q3 2021 | $3,554,000 | +619.4% | 26,491 | +768.6% | 0.02% | +633.3% |
| Q2 2021 | $494,000 | +101.6% | 3,050 | 0.0% | 0.00% | +50.0% |
| Q1 2021 | $245,000 | +47.6% | 3,050 | 0.0% | 0.00% | +100.0% |
| Q4 2020 | $166,000 | +295.2% | 3,050 | +45.2% | 0.00% | – |
| Q3 2020 | $42,000 | -91.4% | 2,100 | -87.7% | 0.00% | -100.0% |
| Q3 2018 | $489,000 | +123.3% | 17,100 | +113.8% | 0.00% | +100.0% |
| Q2 2018 | $219,000 | +29.6% | 8,000 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $169,000 | +9.7% | 8,000 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $154,000 | -22.6% | 8,000 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $199,000 | +48.5% | 8,000 | +1.3% | 0.00% | 0.0% |
| Q2 2017 | $134,000 | – | 7,900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 744,160 | $54,078,000 | 5.79% |
| Discovery Value Fund | 986,173 | $71,665,000 | 5.28% |
| Ally Bridge Group (NY) LLC | 60,000 | $4,360,000 | 3.23% |
| MPM BioImpact LLC | 159,409 | $11,584,000 | 3.11% |
| ARK Investment Management | 8,981,029 | $652,651,000 | 2.72% |
| Elmwood Wealth Management, Inc. | 67,599 | $4,912,000 | 2.52% |
| Nikko Asset Management Americas, Inc. | 2,872,269 | $192,442,000 | 1.41% |
| Frazier Life Sciences Management, L.P. | 203,684 | $14,802,000 | 1.26% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 111,440 | $8,098,000 | 1.22% |
| Merlin Capital, Inc | 11,575 | $841,000 | 1.11% |